Page 13 - Founded Entity News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Search jobs 27-May-2021 PureTech Founded Entity Gelesis Presents Findings on Plenity®-Induced Weight Loss at the American Association of Clinical Endocrinology (AACE) 2021 Annual Virtual Meeting PureTech Founded Entity Gelesis Presents Findings on Plenity®-Induced Weight Loss at the American Association of Clinical Endocrinology (AACE) 2021 Annual Virtual Meeting Analysis showed that treatment for weight management with Plenity resulted in NALFD Fibrosis Score Improvement These data support further clinical investigation using Gelesis’ superab...

Investegate announcements from PureTech Health PLC, PureTech's Akili Secures $160M in Financing

Press release content from Business Wire. The AP news staff was not involved in its creation. PureTech Founded Entity Gelesis Appoints Procter & Gamble Veteran Jane Wildman to Board of Directors April 26, 2021 GMT PureTech Founded Entity, Gelesis, announced the appointment of marketing executive Jane Wildman to its Board of Directors. Ms. Wildman has extensive experience as a board member, president and chief marketing officer across Fortune-25, mid-sized and start-up companies. The appointment comes as Gelesis looks toward the broad United States launch of its commercial product, Plenity® t...

Message : Required fields Ms. Wildman brings extensive experience in brand building and marketing in the consumer health and wellness space, both at established market leaders and start-ups PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, is pleased to note that its Founded Entity, Gelesis, announced the appointment of marketing executive Jane Wildman to its Board of Directors. Ms. Wildman has extensive ...

Posted on 7565 PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, is pleased to note that its Founded Entity, Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, announced that results from the EM...